$1.57 Billion is the total value of Eversept Partners, LP's 107 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 42.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $84,686,074 | +3.2% | 391,920 | -11.8% | 5.41% | -5.0% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $54,306,801 | -23.5% | 403,678 | -9.3% | 3.47% | -29.6% |
| AVTR | Sell | AVANTOR INC | $47,427,095 | -10.2% | 1,125,465 | -12.9% | 3.03% | -17.4% |
| ARKG | Sell | ARK ETF TRgenomic rev etf | $40,693,000 | -21.0% | 664,484 | -3.6% | 2.60% | -27.3% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $35,632,028 | -39.8% | 10,573,302 | -8.9% | 2.28% | -44.6% |
| MCK | Sell | MCKESSON CORP | $33,898,274 | +5.0% | 136,111 | -15.8% | 2.17% | -3.3% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $30,850,340 | -15.7% | 6,440,572 | -6.0% | 1.97% | -22.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INCcall | $20,664,360 | -34.3% | 94,100 | -45.7% | 1.32% | -39.5% |
| OCDX | Sell | ORTHO CLINICAL DIAGNOSTICS H | $18,954,535 | +12.1% | 886,140 | -3.2% | 1.21% | +3.2% |
| RCM | Sell | R1 RCM INC | $18,687,535 | +11.0% | 733,132 | -4.1% | 1.19% | +2.1% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $18,434,999 | -46.8% | 2,301,498 | -35.3% | 1.18% | -51.0% |
| ICLR | Sell | ICON PLC | $16,063,210 | -14.7% | 51,867 | -27.9% | 1.03% | -21.6% |
| FATE | Sell | FATE THERAPEUTICS INC | $14,907,763 | -3.6% | 254,790 | -2.3% | 0.95% | -11.3% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $14,303,468 | -60.4% | 45,522 | -64.5% | 0.91% | -63.5% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $11,709,129 | -22.5% | 384,789 | -14.6% | 0.75% | -28.7% |
| GH | Sell | GUARDANT HEALTH INC | $10,035,407 | -20.0% | 100,334 | -0.0% | 0.64% | -26.4% |
| NTRA | Sell | NATERA INC | $9,532,411 | -23.8% | 102,071 | -9.0% | 0.61% | -29.8% |
| ZGNX | Sell | ZOGENIX INC | $8,953,198 | -23.9% | 550,966 | -28.9% | 0.57% | -30.0% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $8,611,260 | +29.2% | 73,169 | -35.7% | 0.55% | +18.8% |
| PKI | Sell | PERKINELMER INC | $6,206,521 | -23.9% | 30,869 | -34.4% | 0.40% | -30.0% |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $3,678,611 | -77.1% | 87,795 | -73.2% | 0.24% | -79.0% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $3,142,914 | -25.1% | 797,694 | -8.6% | 0.20% | -30.9% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $2,087,354 | -31.7% | 15,934 | -36.3% | 0.13% | -37.3% |
| SNY | Sell | SANOFIsponsored adr | $1,937,467 | -84.5% | 38,672 | -85.1% | 0.12% | -85.7% |
| SRGA | Sell | SURGALIGN HOLDINGS INC | $1,374,587 | -64.1% | 1,918,743 | -45.3% | 0.09% | -66.8% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,307,685 | -43.1% | 348,716 | -21.6% | 0.08% | -47.5% |
| AVRO | Sell | AVROBIO INC | $1,174,208 | -41.5% | 304,989 | -15.2% | 0.08% | -46.0% |
| ACIU | Sell | AC IMMUNE SA | $759,231 | -49.0% | 153,380 | -30.8% | 0.05% | -52.4% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $722,300 | -40.7% | 310,000 | -11.4% | 0.05% | -45.9% |
| LOGC | Sell | LOGICBIO THERAPEUTICS INC | $672,443 | -58.0% | 291,101 | -16.8% | 0.04% | -61.3% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $553,847 | -57.7% | 419,581 | -26.3% | 0.04% | -61.5% |
| GOSS | Sell | GOSSAMER BIO INC | $451,382 | -76.0% | 39,910 | -73.4% | 0.03% | -77.9% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $415,152 | -80.9% | 259,470 | -71.2% | 0.03% | -82.1% |
| FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.02% | – |
| CCRN | Exit | CROSS CTRY HEALTHCARE INC | $0 | – | -20,000 | -100.0% | -0.03% | – |
| Exit | TELIGENT INC NEW | $0 | – | -1,069,465 | -100.0% | -0.03% | – | |
| FREQ | Exit | FREQUENCY THERAPEUTICS INCput | $0 | – | -67,900 | -100.0% | -0.03% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS INcall | $0 | – | -18,700 | -100.0% | -0.04% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.06% | – |
| AMN | Exit | AMN HEALTHCARE SVCS INC | $0 | – | -10,000 | -100.0% | -0.08% | – |
| AKYA | Exit | AKOYA BIOSCIENCES INC | $0 | – | -91,568 | -100.0% | -0.09% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -198,879 | -100.0% | -0.10% | – |
| EDIT | Exit | EDITAS MEDICINE INCput | $0 | – | -50,000 | -100.0% | -0.14% | – |
| NVAX | Exit | NOVAVAX INCcall | $0 | – | -10,000 | -100.0% | -0.14% | – |
| HSTM | Exit | HEALTHSTREAM INC | $0 | – | -77,812 | -100.0% | -0.15% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -47,500 | -100.0% | -0.16% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -43,600 | -100.0% | -0.17% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -100,170 | -100.0% | -0.22% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCcall | $0 | – | -126,400 | -100.0% | -0.29% | – |
| HRC | Exit | HILL-ROM HLDGS INCcall | $0 | – | -29,400 | -100.0% | -0.31% | – |
| HRC | Exit | HILL-ROM HLDGS INC | $0 | – | -30,000 | -100.0% | -0.31% | – |
| GOCO | Exit | GOHEALTH INC | $0 | – | -1,261,723 | -100.0% | -0.44% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -67,000 | -100.0% | -1.26% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -184,299 | -100.0% | -1.70% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -464,801 | -100.0% | -1.93% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -100,000 | -100.0% | -2.98% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -349,494 | -100.0% | -4.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.